Impact on Quality of Life of Osteopathic Visceral Mobilizations After Endometriosis Surgery (MOVENDOP)

January 31, 2025 updated by: University Hospital, Clermont-Ferrand

Impact on Quality of Life of Osteopathic Visceral Mobilizations in Patients Undergoing Post-operative ENDOmetriosis Surgery

One of the most common post-operative complications of gynaecological surgery, and in particular endometriosis surgery, is the formation of peritoneal adhesions. After laparotomy, it affects up to 90% of patients. Minimally invasive techniques (such as laparoscopy) reduce the risk of adhesion formation, but cannot totally prevent it. Adhesions can lead to chronic pelvic pain, dyspareunia, digestive disorders and infertility. Various strategies and devices have been developed to try and limit adhesion formation, but their effectiveness has not been fully proven in the literature. The only real treatment for adhesions is adhesiolysis, although adhesions often reform. The quality of surgery remains the best means of preventing adhesion formation. To reduce the morbidity associated with pelvic adhesions, it is essential to develop alternative, non-invasive, anti-adhesive methods such as manual osteopathic visceral mobilization.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

63

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Clermont-Ferrand, France
        • Recruiting
        • CHU de Clermont-Ferrand
        • Principal Investigator:
          • Nicolas Bourdel
        • Contact:
          • Lise LACLAUTRE

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Woman of legal age
  • Indication for surgery for infiltrating endometriosis
  • Able to give informed consent to participate in research
  • Patient included in NO ENDO (national endometriosis observatory promoted by Clermont-Ferrand University Hospital)

Exclusion Criteria:

  • Indication for surgery for superficial endometriosis
  • Patient of legal age, under guardianship or trusteeship
  • Pregnant or breast-feeding patient
  • Patients not affiliated to the social security system
  • Patients who do not speak French
  • Patients under court protection
  • Simultaneous participation in another study
  • Refusal to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
patients operated for endometriosis without osteopathic visceral mobilization
Experimental: Experimental group
patients operated for endometriosis with osteopathic visceral mobilization
a combination of breathing and visceral mobilizations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life with the EHP-30 questionnaire score
Time Frame: 1 year

Percentage change in baseline questionnaire score (EHP-30) between pre-operative visit and 1 year.

The EHP-30 contains 30 items and ranges from 0 (best health) to 100 (worst health). The items in the baseline questionnaire are grouped into 5 main sub-domains: pain, control and powerlessness, emotional well-being, social support and self-image.

1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
quality of life with score of the questionnaire EHP-30
Time Frame: pre-operative, 6 months and 12 months
Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations
pre-operative, 6 months and 12 months
quality of life with score of the questionnaire GIQLI
Time Frame: pre-operative, 6 months and 12 months
Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations
pre-operative, 6 months and 12 months
quality of life with score of the questionnaire FSFI
Time Frame: pre-operative, 6 months and 12 months
Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations
pre-operative, 6 months and 12 months
quality of life with score of the questionnaire ICIQ-FLUTS
Time Frame: pre-operative, 6 months and 12 months
Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations
pre-operative, 6 months and 12 months
quality of life with score of the questionnaire PCS
Time Frame: pre-operative, 6 months and 12 months
Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations
pre-operative, 6 months and 12 months
pelvic pain
Time Frame: pre-operative, 6 hours after surgery, 1 day after surgery, 1 month after surgery, 6 months and 12 months
Compare pelvic pain between the 2 groups using EVA Scale (Visual Analogic Scale (from 0 : no pain to 10 : worst pain possible)
pre-operative, 6 hours after surgery, 1 day after surgery, 1 month after surgery, 6 months and 12 months
quality of life with the sub-domains of the EHP-30 questionnaire
Time Frame: pre-operative, 6 months and 12 months
Compare changes in patients' quality of life between the 2 groups regarding the sub-domains the EHP-30 questionnaire
pre-operative, 6 months and 12 months
evaluation of the cicatrisation
Time Frame: post operative, 6 months and 12 months
Examination of scar appearance by the surgeon : acquired healing, healing in progress or disunion
post operative, 6 months and 12 months
evaluation of the abdominal flexibility
Time Frame: 1 year
Evaluation of abdominal flexibility with an EVA scale in the regions: right and left iliac fossa, hypogastrium at one year assessed by an independent osteopath between 0 and 10 (0 corresponding to normal flexibility and 10 to total rigidity).
1 year
Use of additional care
Time Frame: 1 year
Compare the use of additional care between the 2 groups by collecting data on the type of consultations (gynecologist, general practitioner, midwife, pain center doctor, emergency doctor, osteopath, physiotherapist, acupuncturist, magnetizer, hypnotherapist, healer, ...) and the number of visits
1 year
consumption of analgesics and hormonal treatment
Time Frame: 1 year
Compare the consumption of analgesics and hormonal treatment (name and dose of the medication) between the 2 groups
1 year
fertility
Time Frame: 1 year
Achieving pregnancy during the first postoperative year (yes or no)
1 year
number of days of sick leave
Time Frame: 1 year
Compare the number of days of sick leave between the two groups
1 year
compare patient profiles using the sub-domains of the EHP-30 questionnaire
Time Frame: 1 year
In the experimental group, identify patient profiles based on the sub-domains of quality of life assessed during the pre-operative visit, and compare these different groups according to the improvement in patients' post-operative quality of life at one year.
1 year
patient compliance
Time Frame: 1 year
evaluate the impact of compliance of patients in the visceral mobilization group on improved quality of life and abdominal flexibility (by collecting the number of osteopathic self-mobilizations performed each month following surgery and during1 year)
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nicolas Bourdel, University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 27, 2025

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2028

Study Registration Dates

First Submitted

August 8, 2024

First Submitted That Met QC Criteria

August 12, 2024

First Posted (Actual)

August 14, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 31, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • RBHP 2023 BOURDEL
  • 2023-A02653-42 (Other Identifier: 2023-A02653-42)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endometriosis

Clinical Trials on osteopatic visceral mobilization

Subscribe